Acerta Prolonged Release Tablets

Indication

Attention Deficit Hyperactivity Disorder (ADHD) in children and adults, and narcolepsy.

Dosage (summary)

Initial dose is typically 18 mg once daily, may be adjusted in increments of 9 mg weekly; maximum dose is 54 mg per day.

Onset of Action / Duration

Effects may be observed within 30 to 60 minutes after administration, with a duration of action lasting up to 12 hours.

Special Populations

• Pediatric patients
• Geriatric patients
• Patients with hepatic impairment
• Patients with renal impairment

Pregnancy & Breastfeeding

Methylphenidate is classified as Category C. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Caution is advised during lactation as it is excreted in breast milk.

Key Drug Interactions

• Monoamine oxidase inhibitors (MAOIs)
• Antidepressants
• Antihypertensives
• Anticonvulsants
• Alcohol

Contraindications

• Hypersensitivity to methylphenidate or any component of the formulation
• Glaucoma
• Severe anxiety, tension, or agitation
• History of drug abuse
• Cardiovascular disorders

Common side effects

• Insomnia
• Decreased appetite
• Nausea
• Headache
• Dry mouth
• Increased heart rate
• Anxiety

Counselling Points

• Take the medication as prescribed, do not exceed the recommended dose.
• Monitor for any changes in mood or behavior.
• Avoid alcohol and other central nervous system stimulants.
• Report any cardiovascular symptoms to a healthcare provider.
• Regular follow-up appointments are necessary to assess efficacy and side effects.